Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency

Obstetrics and Gynecology

Volumn 96, Issue 2, 2000, Pages 243-249

  Saaresranta, Tarja ^a,c   Irjala, Kerttu ^a   Polo Kantola, Päivi ^a,c   Helenius, Hans ^a,b   Polo, Olli ^a,c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Universität Turku   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPERCAPNIA; HYPOXEMIA; POSTMENOPAUSE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SINGLE BLIND PROCEDURE;

CHRONIC DISEASE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE CONGENERS; RESPIRATORY INSUFFICIENCY; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0033937560     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00897-8     Document Type: Article

References (47)

1. Skatrud J.B., Dempsey J.A., Kaiser D.G. Ventilatory responses to medroxyprogesterone acetate in normal subjects Time course and mechanism . J Appl Physiol. 44:1978;939-944.
2. Zwillich C.W., Natalino M.R., Sutton F.D., Weil J.V. Effects of progesterone on chemosensitivity in normal men. J Lab Clin Med. 92:1978;262-269.
3. Popovic R.M., White D.P. Upper airway muscle activity in normal women Influence of hormonal status . J Appl Physiol. 84:1998;1055-1062.
4. Saaresranta T., Polo-Kantola P., Irjala K., Helenius H., Polo O. Respiratory insufficiency in postmenopausal women. Sustained improvement of gas exchange with short-term medroxyprogesterone acetate. Chest. 115:1999;1581-1587.
5. Lee P.A. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child. 135:1981;443-445.
6. Selman P.J., Mol J.A., Rutteman G.R., Rijnberk A. Progestin treatment in the dog. I. Effects of growth hormone, insulin-like growth factor I and glucose homeostasis. Eur J Endocrinol. 131:1994;413-421.
7. Laatikainen T., Nieminen U., Adlercreutz H. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma. Acta Obstet Gynecol Scand. 58:1979;95-99.
8. Press M.F., Greene G.L. Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology. 122:1988;1165-1175.
9. Pasanen S., Ylikomi T., Syvälä H., Tuohimaa P. Distribution of progesterone receptor in chicken Novel target organs for progesterone and estrogen action . Mol Cell Endocrinol. 135:1997;79-91.
10. Carroll R.S., Zhang J., Dashner K., Black P.M. Progesterone and glucocorticoid receptor activation in meningeomas. Neurosurgery. 37:1995;92-97.
11. Wilson C.M., McPhaul M.J. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol. 120:1996;51-57.
12. Chrapusta S., Grieb P. Evidence for sex steroid receptors in feline brainstem. Neurosci Lett. 142:1992;167-170.
13. Mendelson C.R., MacDonald P.C., Johnston J.M. Estrogen binding in human fetal lung tissue cytosol. Endocrinology. 106:1980;368-374.
14. Ben-Harari R.R., Amit T., Youdim M.B.H. Binding of oestradiol, progesterone and prolactin in rat lung. J Endocrinol. 97:1983;301-310.
15. Amit T., Barkey R.J., Youdim M.B.H. Specific binding sites for prolactin and growth hormone in the adult rabbit lung. Mol Cell Endocrinol. 49:1987;17-24.
16. Lei Z.M., Rao C.V., Kornyei J.L., Licht P., Hiatt E.S. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 132:1993;2262-2270.
17. Lehmann E.L. Nonparametrics Statistical methods based on ranks . 1975;Holden-Day, Inc, San Francisco.
18. Crowder M.J., Hand D.J. Analysis of repeated measures. 1990;City and Hall, London.
19. Gardner M.J., Altman D.G. Statistics with confidence. 1989;British Medical Journal, London.
20. Block A.J., Wynne J.W., Boysen P.G. Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women. Am J Med. 69:1980;75-79.
21. Leavitt W.W., Blaha G.C. An estrogen-stimulated, progesterone-binding system in the hamster uterus and vagina. Steroids. 19:1972;263-274.
22. Sadoff L., Lusk W. The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol, T4, LH and testosterone in patients with advanced cancer. Obstet Gynecol. 43:1974;262-267.
23. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 42:1976;247-253.
24. Lundgren S., Lønning P.E., Utaaker E., Aakvaag A., Kvinnsland S. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer. I. General findings. J Steroid Biochem. 36:1990;99-104.
25. Petsos P., Ratcliffe W.A., Anderson D.C. Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome. Clin Endocrinol Oxf. 25:1986;651-660.
26. Buckler H.M., Anderson D.C. The perimenopausal state and incipient ovarian failure. Lobo R.A. Treatment of the postmenopausal woman. 1st ed. 1994;11-23 Raven Press, New York.
27. Gow S.M., Seth J., Beckett G.J., Douglas G. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax. 42:1987;520-525.
28. Saarni H.U., Rautio A., Kärki N.T., Sotaniemi E.A. Disposition of medroxyprogesterone acetate and drug metabolism activity. Res Commun Chem Pathol Pharmacol. 39:1983;251-260.
29. White D.P., Schneider B.K., Santen R.J., McDermott M., Pickett C.K., Zwillich C.W., et al. Influence of testosterone on ventilation and chemosensitivity in male subjects. J Appl Physiol. 59:1985;1452-1457.
30. Schneider B.K., Pickett C.K., Zwillich C.W., Weil J.V., McDermott M.T., Santen R.J., et al. Influence of testosterone on breathing during sleep. J Appl Physiol. 61:1986;618-623.
31. Poulin R., Simard J., Labrie C., Petitclerc L., Dumont M., Lagacé L., et al. Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology. 125:1989;392-399.
32. Scheele F., Hompes P.G.A., Gooren L.J.G., Spijkstra J.J., Spinder T. The effects of 6 weeks testosterone treatment on pulsatile luteinizing hormone secretion in eugonadal female-to-male transsexuals. Fertil Steril. 55:1991;608-611.
33. Dowsett M., Lal A., Smith I.E., Jeffcoate S.L. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. Br J Cancer. 55:1987;311-313.
34. Jeppsson S., Gershagen S., Johansson E.D., Rannevik G. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh). 99:1982;339-343.
35. Anderson D.C. Sex-hormone-binding globulin. Clin Endocrinol. 3:1974;69-96.
36. Von Schoultz B., Carlström K. On the regulation of sex-hormone-binding globulin A challenge of an old dogma and outlines of an alternative mechanism . J Steroid Biochem. 32:1989;327-334.
37. Pugeat M., Crave J.C., Elmidani M., Nicolas M.H., Garoscio-Cholet M., Lejeune H., et al. Pathophysiology of sex hormone binding globulin (SHBG) Relation to insulin . J Steroid Biochem Mol Biol. 40:1991;841-849.
38. Botwood N., Hamilton-Fairley D., Kiddy D., Robinson S., Franks S. Sex hormone-binding globulin and female reproductive function. J Steroid Biochem Mol Biol. 53:1995;529-531.
39. Semmens J.B., Rouse I.L., Beilin L.J., Masarei J.R.L. Relationships between age, body weight, physical fitness and sex-hormone-binding globulin capacity. Clin Chim Acta. 133:1983;295-300.
40. Longcope C., Goldfield S.R.W., Brambilla D.J., McKinlay J. Androgens, estrogens, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab. 71:1990;1442-1446.
41. Vesterinen E., Backas N.E., Pesonen K., Stenman U.H., Laatikainen T. Effect of medroxyprogestrone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma. Arch Gynecol. 230:1981;205-211.
42. Schiff I., Tulchinsky D., Cramer D., Ryan K.J. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA. 244:1980;1443-1445.
43. Blossey H.C., Wander H.E., Koebberling J., Nagel G.A. Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer. 54:1984;1208-1215.
44. Smith Y.F., Mullon D.K., Hamosh M., Scanlon J.W., Hamosh P. Serum prolactin and respiratory distress syndrome in the newborn. Pediatr Res. 14:1980;93-95.
45. Knudtzon J., Bogsnes A., Norman N. Changes in prolactin and growth hormone levels during hypoxia and exercise. Horm Metab Res. 21:1989;453-454.
46. Strüder H.K., Hollmann W., Donike M., Platen P., Weber K. Effect of O2 availability on neuroendocrine variables at rest and during exercise O2 breathing increases plasma prolactin . Eur J Appl Physiol. 74:1996;443-449.
47. Semple Pd'A., Watson W.S., Beastall G.H., Hume R. Endocrine and metabolic studies in unstable cor pulmonale. Thorax. 38:1983;45-49.